San Diego, CA -- (SBWire) -- 11/18/2022 --Certain directors of Co-Diagnostics, Inc are under investigation over potential breaches of fiduciary duties.
Investors who are investors in Co-Diagnostics, Inc. (NASDAQ: CODX) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: CODX stocks follows a lawsuit filed against Co-Diagnostics, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: CODX stocks, concerns whether certain Co-Diagnostics, Inc. directors are liable in connection with the allegations made in that lawsuit.
The plaintiff alleges that, the Defendants repeatedly touted its Logix Smart™ COVID-19 Test, reassuring investors about the demand for the product, that at the same time, the Defendants failed to disclose that demand for its Logix Smart™ COVID-19 Test had plummeted throughout the quarter ended June 30, 2022, and that as a result, Defendants' positive statements about the demand for its Logix Smart™ COVID-19 Test lacked a reasonable basis.
Those who purchased shares of Co-Diagnostics, Inc. (NASDAQ: CODX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
Co-Diagnostics, Inc. (NASDAQ:CODX) Long Term Shareholder Notice: Investigation over Possible Wrongdoing
An investigation on behalf of current long term investors in Co-Diagnostics, Inc. (NASDAQ:CODX) shares over possible breaches of fiduciary duty by certain officers and directors was announced.